Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer

医学 脂肪性肝炎 氧化应激 药理学 脂肪肝 肝硬化 肝细胞癌 血管生成 肝再生 肝细胞 癌症研究 肝癌 癌症 肝损伤 内科学 再生(生物学) 化学 生物 体外 生物化学 疾病 细胞生物学
作者
János Fehér,Gabriella Lengyel
出处
期刊:Current Pharmaceutical Biotechnology [Bentham Science]
卷期号:13 (1): 210-217 被引量:213
标识
DOI:10.2174/138920112798868818
摘要

In chronic liver diseases caused by oxidative stress (alcoholic and non-alcoholic fatty liver diseases, drug- and chemical-induced hepatic toxicity), the antioxidant medicines such as silymarin can have beneficial effect. Liver cirrhosis, non-alcoholic fatty liver and steatohepatitis are risk factors for hepatocellular carcinoma (HCC). Insulin resistance and oxidative stress are the major pathogenetic mechanisms leading the hepatic cell injury in these patients. The silymarin exerts membrane-stabilizing and antioxidant activity, it promotes hepatocyte regeneration; furthermore it reduces the inflammatory reaction, and inhibits the fibrogenesis in the liver. These results have been established by experimental and clinical trials. According to open studies the long-term administration of silymarin significantly increased survival time of patients with alcohol induced liver cirrhosis. Based on the results of studies using methods of molecular biology, silymarin can significantly reduce tumor cell proliferation, angiogenesis as well as insulin resistance. Furthermore, it exerts an anti-atherosclerotic effect, and suppresses tumor necrosis factor-alpha-induced protein production and mRNA expression due to adhesion molecules. The chemopreventive effect of silymarin on HCC has been established in several studies using in vitro and in vivo methods; it can exert a beneficial effect on the balance of cell survival and apoptosis by interfering cytokines. In addition to this, anti-inflammatory activity and inhibitory effect of silymarin on the development of metastases have also been detected. In some neoplastic diseases silymarin can be administered as adjuvant therapy as well. Keywords: Cancer prevention, chronic liver diseases, hepatitis B virus, hepatitis C virus, hepatocellular carcinoma, silymarin, steatohepatitis, oxidative stress, Liver cirrhosis, membrane-stabilizing, insulin resistance, metastases, adjuvant therapy, hepatobiliary diseases

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
Magic1987发布了新的文献求助10
1秒前
充电宝应助无白开采纳,获得10
1秒前
舒心梦琪完成签到,获得积分10
2秒前
无敌猫饭发布了新的文献求助10
2秒前
哪位完成签到,获得积分10
3秒前
3秒前
zz发布了新的文献求助10
3秒前
4秒前
夏柯完成签到,获得积分10
4秒前
4秒前
XX完成签到,获得积分10
4秒前
4秒前
bkagyin应助满意语芙采纳,获得10
4秒前
黑猫乾杯应助科研通管家采纳,获得10
4秒前
小二郎应助科研通管家采纳,获得30
5秒前
Mic应助科研通管家采纳,获得10
5秒前
做科研的小施同学完成签到,获得积分10
5秒前
脑洞疼应助科研通管家采纳,获得10
5秒前
田様应助科研通管家采纳,获得10
5秒前
科目三应助科研通管家采纳,获得30
5秒前
小巧亦竹发布了新的文献求助10
5秒前
酷波er应助科研通管家采纳,获得10
5秒前
斯文败类应助科研通管家采纳,获得10
5秒前
赘婿应助科研通管家采纳,获得30
5秒前
小单发布了新的文献求助50
5秒前
王丽娟应助科研通管家采纳,获得10
5秒前
共享精神应助科研通管家采纳,获得10
5秒前
Jared应助科研通管家采纳,获得10
5秒前
5秒前
妩媚的海应助科研通管家采纳,获得10
5秒前
彭于晏应助科研通管家采纳,获得10
5秒前
smottom应助科研通管家采纳,获得10
5秒前
5秒前
华仔应助科研通管家采纳,获得10
5秒前
星月应助科研通管家采纳,获得20
5秒前
黑猫乾杯应助科研通管家采纳,获得10
6秒前
科研通AI6应助Magic1987采纳,获得10
6秒前
丘比特应助科研通管家采纳,获得10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Reproduction Third Edition 3000
Comprehensive Methanol Science Production, Applications, and Emerging Technologies 2000
化妆品原料学 1000
Psychology of Self-Regulation 800
1st Edition Sports Rehabilitation and Training Multidisciplinary Perspectives By Richard Moss, Adam Gledhill 600
Red Book: 2024–2027 Report of the Committee on Infectious Diseases 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5642103
求助须知:如何正确求助?哪些是违规求助? 4758150
关于积分的说明 15016411
捐赠科研通 4800600
什么是DOI,文献DOI怎么找? 2566140
邀请新用户注册赠送积分活动 1524244
关于科研通互助平台的介绍 1483901